Skip to main content
. 2010 Oct 5;2(1):69–73. doi: 10.3892/ol.2010.196

Figure 3.

Figure 3

Chronological alterations of VEGF and sVEGFR-2 during 12 months of treatment in patients in the treated group without HCC recurrence. VEGF expression gradually decreased, and the expression level at 6 months after treatment was statistically significant as compared to the pre-treatment basal level. The decrease in sVEGFR-2 expression occurred earlier than that of VEGF. sVEGFR-2 expression was noted to have already significantly decreased at 3 months after ACE-I and VK combination treatment. The data represent the means ± SD (n=25). *Statistically significant differences as compared to the pre-treatment basal level (p<0.01).